Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
99.13
+0.13 (0.13%)
At close: Mar 17, 2026, 4:00 PM EDT
97.21
-1.92 (-1.94%)
After-hours: Mar 17, 2026, 5:39 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $19.64 billion as of March 17, 2026. Its market cap has increased by 175.61% in one year.
Market Cap
19.64B
Enterprise Value
18.05B
1-Year Change
175.61%
Ranking
Category
Stock Price
$99.13
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $19.64B, an increase of 1,094.60%. That is a compound annual growth rate of 50.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 19.64B | 27.58% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 32.11B |
| Insmed | 31.17B |
| BioNTech SE | 22.75B |
| Moderna | 21.05B |
| Roivant Sciences | 20.24B |
| Royalty Pharma | 19.75B |
| Incyte | 18.51B |
| Genmab | 17.06B |